During the past decade, MVZ Portal 10 conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MVZ Portal 10" are "Crohn Disease" (2 trials), "Colitis, Ulcerative" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "MVZ Portal 10" in a lesser frequency.

Most popular intervention types in "MVZ Portal 10" are "Biological" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Golimumab" (2 trials), "Guselkumab" (2 trials), "JNJ-78934804" (2 trials), "Placebo" (2 trials) and "Adalimumab (40 mg)" (1 trials). Other intervention names were less common.

The vast majority of trials in "MVZ Portal 10" are 4 trials for "All" genders.

Currently, there are NaN active trials in "MVZ Portal 10". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in MVZ Portal 10, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MVZ Portal 10, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".